Related references
Note: Only part of the references are listed.Heparin-induced thrombocytopenia following hip and knee arthroplasty
Johnathan D. Craik et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Estimating Quality of Life in Acute Venous Thrombosis
Kerstin Hogg et al.
JAMA INTERNAL MEDICINE (2013)
New oral anticoagulants after total knee arthroplasty: clinical considerations for orthopaedic surgeons
James Kudrna
CURRENT ORTHOPAEDIC PRACTICE (2013)
Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies
Krystin Krauel et al.
BLOOD (2012)
New oral anticoagulants for preventing venous thromboembolism
Elliott R. Haut et al.
BRITISH MEDICAL JOURNAL (2012)
Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons
Antonio Gomez-Outes et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
The practical management of intracerebral hemorrhage associated with oral anticoagulant therapy
Luca Masotti et al.
INTERNATIONAL JOURNAL OF STROKE (2011)
Economic impact of an electronic alert system to prevent venous thromboembolism in hospitalised patients
R. Lecumberri et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty
O. E. Dahl et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
New oral anticoagulant drugs in cardiovascular disease
Ingo Ahrens et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Economic Evaluation of Dabigatran Etexilate for the Prevention of Venous Thromboembolism After Total Knee and Hip Replacement Surgery
Sorrel E. Wolowacz et al.
CLINICAL THERAPEUTICS (2009)
New Anticoagulants: Focus on Venous Thromboembolism
Antonio Gomez-Outes et al.
CURRENT VASCULAR PHARMACOLOGY (2009)
The costs of heparin-induced thrombocytopenia: a patient-based cost of illness analysis
T. Wilke et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Will oral rivaroxaban improve clinically relevant outcomes and thromboprophylaxis management in the orthopedic patient?
A. Gomez-Outes et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Rivaroxaban versus enoxaparin after total knee arthroplasty
Antonio Gomez-Outes et al.
LANCET (2009)
Epidemiología hospitalaria de la enfermedad tromboembólica venosa en España
Ricardo Guijarro Merino et al.
MEDICINA CLINICA (2009)
The epidemiology of venous thromboembolism in the community
John A. Heit
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Assessing differences in utility scores: A comparison of four widely used preference-based instruments
Hwee-Lin Wee et al.
VALUE IN HEALTH (2007)
Effectiveness of hip or knee replacement surgery in terms of quality-adjusted life years and costs
Pirjo Rasanen et al.
ACTA ORTHOPAEDICA (2007)
Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events - Findings from the global orthopaedic registry
D. Warwick et al.
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME (2007)
Low-molecular-weight heparin, bemiparin, in the outpatient treatment and secondary prophylaxis of venous thromboembolism in standard clinical practice:: the ESFERA Study
A Santamaría et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis
P Haentjens et al.
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY (2004)
Pharmacoeconomic analysis of bemiparin and enoxaparin as prophylaxis for venous thromboembolism in total knee replacement surgery
J Honorato et al.
PHARMACOECONOMICS (2004)
The economics of venous thromboembolism prophylaxis - A primer for clinicians
BL Davidson et al.
CHEST (2003)
Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery
SD Sullivan et al.
PHARMACOECONOMICS (2003)
The epidemiology of venous thromboembolism in the community
JA Heit et al.
THROMBOSIS AND HAEMOSTASIS (2001)